Skip to main content
NCBI home page
Scientific Reports logoLink to Scientific Reports
. 2024 Mar 4;14:5311. doi: 10.1038/s41598-024-55673-7

Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel

Tsuyoshi Shirakawa 1,2, Akitaka Makiyama 3,4, Mototsugu Shimokawa 5,6, Taiga Otsuka 7,8, Yudai Shinohara 3, Futa Koga 9, Yujiro Ueda 10, Junichi Nakazawa 11, Satoshi Otsu 12, Azusa Komori 12,13, Shiho Arima 14, Masaru Fukahori 15,16, Hiroki Taguchi 17,18, Takuya Honda 19, Taro Shibuki 20,21, Kenta Nio 22,23, Yasushi Ide 24,25, Norio Ureshino 26,7, Toshihiko Mizuta 20,27, Kenji Mitsugi 22,23,✉, Koichi Akashi 28, Eishi Baba 29
PMCID: PMC10912623  PMID: 38438505

Correction to: Scientific Reports 10.1038/s41598-023-34962-7, published online 31 May 2023

The original version of this Article contained an error in the Supplementary Information File, where the Kaplan–Meier curves and numbers at risk were incorrect.

The original Supplementary Information file is provided below.

The original Article has been corrected.

Supplementary Information

Supplementary Information. (7.6MB, pdf)

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-55673-7.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information. (7.6MB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES